Hojabr Alimi

Chief Executive Officer at

Plex Pharmaceuticals, Inc.

64 year

22 connections

Health Technology

Health Services

Commercial Services

Profile

Mr. Hojabr Alimi is a Chairman & Chief Executive Officer at Collidion, Inc. (California), a Chairman & Chief Executive Officer at Plex Pharmaceuticals, Inc. and a Chairman & Chief Executive Officer at Spectrum Antimicrobials, Inc. Mr. Alimi was previously employed as a Chairman & Chief Science Officer by Ruthigen, Inc., a Chairman by Oculus Innovative Sciences, Inc., a President & Chief Executive Officer by MicroMed Laboratories, Inc., a Corporate Microbiologist & Chief Scientist by Arterial Vascular Engineering, Inc., and a Chief Executive & Science Officer by Pulmatrix, Inc. He received his undergraduate degree from Sonoma State University.

Hojabr Alimi active positions

Companies	Position	Start
Plex Pharmaceuticals, Inc. Plex Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides treatment of diseases generally by protein misfolding	Chief Executive Officer	-
Collidion, Inc. (California) Collidion, Inc. (California) Medical/Nursing ServicesHealth Services Provides healthcare service	Chief Executive Officer	-
Spectrum Antimicrobials, Inc. Spectrum Antimicrobials, Inc. Medical/Nursing ServicesHealth Services Provides infection treatment services	Chief Executive Officer	-

All active positions of Hojabr Alimi

Former positions of Hojabr Alimi

Companies	Position	End
SONOMA PHARMACEUTICALS, INC.	Founder	26/03/2014
MicroMed Laboratories, Inc. MicroMed Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides environmental monitoring and testing laboratory services	President	01/01/2002
Arterial Vascular Engineering, Inc. Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters	Chief Tech/Sci/R&D Officer	-
PULMATRIX, INC.	Chief Executive Officer	-
Ruthigen, Inc. Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapies to address serious pulmonary disease	Chief Executive Officer	19/06/2015

See the detail of Hojabr Alimi's experience

Training of Hojabr Alimi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hojabr Alimi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Arterial Vascular Engineering, Inc. Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters	Health Technology
Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid	Health Technology
MicroMed Laboratories, Inc. MicroMed Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides environmental monitoring and testing laboratory services	Commercial Services
Sonoma State University Sonoma State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Plex Pharmaceuticals, Inc. Plex Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides treatment of diseases generally by protein misfolding	Health Services
Ruthigen, Inc. Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapies to address serious pulmonary disease	Health Technology
Pulmatrix, Inc. Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease	Health Technology
Collidion, Inc. (California) Collidion, Inc. (California) Medical/Nursing ServicesHealth Services Provides healthcare service	Health Services
Spectrum Antimicrobials, Inc. Spectrum Antimicrobials, Inc. Medical/Nursing ServicesHealth Services Provides infection treatment services	Health Services